Physician profile
Patrick Christopher Yee
NPI 1609892520
$2,230.10
in general payments reported to CMS, 2019-2025
23 companies · $637 in 2025
The $637 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $46.16 · 2022: $297 · 2023: $399 · 2024: $483 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $854.85 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $148.96 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $146.05 | 2019-2024 | |
| Glaxosmithkline, LLC. | $131.07 | 2019-2024 | Bexsero |
| Pfizer INC. | $114.21 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $107.99 | 2022-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Tris Pharma INC | $99.31 | 2019-2022 | |
| Neos Therapeutics, Lp | $98.23 | 2019-2025 | Cotempla Xr-Odt |
| Cranial Technologies, INC | $64.70 | 2019-2025 | Doc Band |
| Kaleo, INC. | $63.18 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $56.03 | 2022-2024 | Qelbree |
| Noven Therapeutics, LLC | $48.16 | 2024-2025 | Xelstrym |
| Sanofi-Aventis U.S. LLC | $45.87 | 2023-2024 | |
| Sobi, INC | $44.99 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.88 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $32.28 | 2019-2023 | Immunocap |
| Alk-Abello, INC | $24.04 | 2025 | Neffy, Odactra, Grastek |
| Qiagen, LLC | $23.40 | 2022 | |
| Verrica Pharmaceuticals INC. | $22.37 | 2025 | Ycanth |
| Shire North American Group INC | $22.34 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.45 | 2019 | |
| Adlon Therapeutics L.P. | $17.95 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.